UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 228

Sortiert nach

Improved Survival with Bevacizumab in Advanced Cervical Cancer

The New England journal of medicine, 2014-02, Vol.370 (8), p.734-743

2014

Link zum Volltext

Verfügbarkeit prüfen

Bevacizumab for advanced cervical cancer: patient-reported outcomes of a randomised, phase 3 trial (NRG Oncology–Gynecologic Oncology Group protocol 240)

The lancet oncology, 2015-03, Vol.16 (3), p.301-311

2015

Link zum Volltext

Verfügbarkeit prüfen

Management of Metastatic Cervical Cancer: Review of the Literature

Journal of clinical oncology, 2007-07, Vol.25 (20), p.2966-2974

Long, 3rd, Harry J

2007

Link zum Volltext

Verfügbarkeit prüfen

Oncolytic measles virus expressing the sodium iodide symporter to treat drug-resistant ovarian cancer

Cancer research (Chicago, Ill.), 2015-01, Vol.75 (1), p.22-30

2015

Link zum Volltext

Verfügbarkeit prüfen

Randomized Phase III Trial of Cisplatin With or Without Topotecan in Carcinoma of the Uterine Cervix: A Gynecologic Oncology Group Study

Journal of clinical oncology, 2005-07, Vol.23 (21), p.4626-4633

2005

Link zum Volltext

Verfügbarkeit prüfen

Phase I Trial of Intraperitoneal Administration of an Oncolytic Measles Virus Strain Engineered to Express Carcinoembryonic Antigen for Recurrent Ovarian Cancer

Cancer research (Chicago, Ill.), 2010-02, Vol.70 (3), p.875-882

2010

Link zum Volltext

Verfügbarkeit prüfen

Role of Imaging in Pretreatment Evaluation of Early Invasive Cervical Cancer: Results of the Intergroup Study American College of Radiology Imaging Network 6651–Gynecologic Oncology Group 183

Journal of clinical oncology, 2005-12, Vol.23 (36), p.9329-9337

2005

Link zum Volltext

Verfügbarkeit prüfen

Prognostic factors for response to cisplatin-based chemotherapy in advanced cervical carcinoma: A Gynecologic Oncology Group Study

Gynecologic oncology, 2010-01, Vol.116 (1), p.44-49

2010

Link zum Volltext

Verfügbarkeit prüfen

Prospective Validation of Pooled Prognostic Factors in Women with Advanced Cervical Cancer Treated with Chemotherapy with/without Bevacizumab: NRG Oncology/GOG Study

Clinical cancer research, 2015-12, Vol.21 (24), p.5480-5487

2015

Link zum Volltext

Verfügbarkeit prüfen

Quality of Life Outcomes From a Randomized Phase III Trial of Cisplatin With or Without Topotecan in Advanced Carcinoma of the Cervix: A Gynecologic Oncology Group Study

Journal of clinical oncology, 2005-07, Vol.23 (21), p.4617-4625

2005

Link zum Volltext

Verfügbarkeit prüfen

Comparative outcomes assessment of uterine grade 3 endometrioid, serous, and clear cell carcinomas

Gynecologic oncology, 2013-06, Vol.129 (3), p.478-485

2013

Link zum Volltext

Verfügbarkeit prüfen

Quality of life and survival in advanced cervical cancer: A Gynecologic Oncology Group study

Gynecologic oncology, 2012-05, Vol.125 (2), p.315-319

2012

Link zum Volltext

Verfügbarkeit prüfen

Utilization of Diagnostic Studies in the Pretreatment Evaluation of Invasive Cervical Cancer in the United States: Results of Intergroup Protocol ACRIN 6651/GOG 183

Journal of clinical oncology, 2005-10, Vol.23 (30), p.7454-7459

2005

Link zum Volltext

Verfügbarkeit prüfen

Aromatase inhibitors in the treatment of recurrent ovarian granulosa cell tumors: Brief report and review of the literature

The journal of obstetrics and gynaecology research, 2012-01, Vol.38 (1), p.340-344

2012

Link zum Volltext

Verfügbarkeit prüfen

Factors Associated With Grade 3 or 4 Treatment-Related Toxicity in Women With Advanced or Recurrent Cervical Cancer: An Exploratory Analysis of NRG Oncology/Gynecologic Oncology Group Trials 179 and 204

International journal of gynecological cancer, 2015-02, Vol.25 (2), p.303-308

2015

Link zum Volltext

Verfügbarkeit prüfen

High-risk endometrial cancer subgroups: candidates for target-based adjuvant therapy

Gynecologic oncology, 2004-10, Vol.95 (1), p.120-126

2004

Link zum Volltext

Verfügbarkeit prüfen

A randomized phase III trial in advanced endometrial carcinoma of surgery and volume directed radiation followed by cisplatin and doxorubicin with or without paclitaxel: A Gynecologic Oncology Group study

Gynecologic oncology, 2009-03, Vol.112 (3), p.543-552

2009

Link zum Volltext

Verfügbarkeit prüfen

Intraperitoneal Radioactive Phosphorus (32P) Versus Observation After Negative Second-Look Laparotomy for Stage III Ovarian Carcinoma: A Randomized Trial of the Gynecologic Oncology Group

Journal of clinical oncology, 2003-08, Vol.21 (15), p.2849-2855

2003

Link zum Volltext

Verfügbarkeit prüfen

A Phase I Clinical Trial of the Poly(ADP-ribose) Polymerase Inhibitor Veliparib and Weekly Topotecan in Patients with Solid Tumors

Clinical cancer research, 2018-02, Vol.24 (4), p.744-752

2018

Link zum Volltext

Verfügbarkeit prüfen

Phase III Trial of Paclitaxel at Two Dose Levels, the Higher Dose Accompanied by Filgrastim at Two Dose Levels in Platinum-Pretreated Epithelial Ovarian Cancer: An Intergroup Study

Journal of clinical oncology, 2003-08, Vol.21 (15), p.2843-2848

2003

Link zum Volltext

Verfügbarkeit prüfen

Impact of tumour histology on survival in advanced cervical carcinoma: an NRG Oncology/Gynaecologic Oncology Group Study

British journal of cancer, 2018-01, Vol.118 (2), p.162-170

2018

Link zum Volltext

Verfügbarkeit prüfen

Clinical results and quality of life analysis for the MVAC combination (methotrexate, vinblastine, doxorubicin, and cisplatin) in carcinoma of the uterine cervix: A Gynecologic Oncology Group study

Gynecologic oncology, 2006-03, Vol.100 (3), p.537-543

2006

Link zum Volltext

Verfügbarkeit prüfen

Influence of race on tolerance of platinum-based chemotherapy and clinical outcomes in women with advanced and recurrent cervical cancer: a pooled analysis of 3 Gynecologic Oncology Group studies

American journal of obstetrics and gynecology, 2008-11, Vol.199 (5), p.539.e1-539.e6

2008

Link zum Volltext

Verfügbarkeit prüfen

Prevention, Diagnosis, and Treatment of Cervical Cancer

Mayo Clinic proceedings, 2007-12, Vol.82 (12), p.1566-1574

2007

Link zum Volltext

Verfügbarkeit prüfen

Phase II trial of dacarbazine, mitomycin, doxorubicin, and cisplatin with sargramostim in uterine leiomyosarcoma: A Gynecologic Oncology Group study

Gynecologic oncology, 2005-11, Vol.99 (2), p.339-342

2005

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 228

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(207)
Mit Volltextzugriff
(184)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

Englisch
(226)
Japanisch
(31)
Deutsch
(1)

Erscheinungsjahr

n.n

Thema

Science & Technology
(153)
Humans
(138)
Life Sciences & Biomedicine
(136)
Female
(91)
Biological And Medical Sciences
(71)
Medical Sciences
(68)
Middle Aged
(63)
Adult
(60)
Oncology
(58)
Aged
(52)
Male
(42)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(37)
Pediatrics
(33)
Pharmacology. Drug Treatments
(32)
Chemotherapy
(25)
Child
(25)
Antineoplastic Agents
(24)
United States
(24)
Cisplatin - Administration & Dosage
(23)
Obstetrics & Gynecology
(21)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Improved Survival with Bevacizumab in Advanced Cervical Cancer

Bevacizumab for advanced cervical cancer: patient-reported outcomes of a randomised, phase 3 trial (NRG Oncology–Gynecologic Oncology Group protocol 240)

Management of Metastatic Cervical Cancer: Review of the Literature

Oncolytic measles virus expressing the sodium iodide symporter to treat drug-resistant ovarian cancer

Randomized Phase III Trial of Cisplatin With or Without Topotecan in Carcinoma of the Uterine Cervix: A Gynecologic Oncology Group Study

Phase I Trial of Intraperitoneal Administration of an Oncolytic Measles Virus Strain Engineered to Express Carcinoembryonic Antigen for Recurrent Ovarian Cancer

Role of Imaging in Pretreatment Evaluation of Early Invasive Cervical Cancer: Results of the Intergroup Study American College of Radiology Imaging Network 6651–Gynecologic Oncology Group 183

Prognostic factors for response to cisplatin-based chemotherapy in advanced cervical carcinoma: A Gynecologic Oncology Group Study

Prospective Validation of Pooled Prognostic Factors in Women with Advanced Cervical Cancer Treated with Chemotherapy with/without Bevacizumab: NRG Oncology/GOG Study

Quality of Life Outcomes From a Randomized Phase III Trial of Cisplatin With or Without Topotecan in Advanced Carcinoma of the Cervix: A Gynecologic Oncology Group Study

Comparative outcomes assessment of uterine grade 3 endometrioid, serous, and clear cell carcinomas

Quality of life and survival in advanced cervical cancer: A Gynecologic Oncology Group study

Utilization of Diagnostic Studies in the Pretreatment Evaluation of Invasive Cervical Cancer in the United States: Results of Intergroup Protocol ACRIN 6651/GOG 183

Aromatase inhibitors in the treatment of recurrent ovarian granulosa cell tumors: Brief report and review of the literature

Factors Associated With Grade 3 or 4 Treatment-Related Toxicity in Women With Advanced or Recurrent Cervical Cancer: An Exploratory Analysis of NRG Oncology/Gynecologic Oncology Group Trials 179 and 204

High-risk endometrial cancer subgroups: candidates for target-based adjuvant therapy

A randomized phase III trial in advanced endometrial carcinoma of surgery and volume directed radiation followed by cisplatin and doxorubicin with or without paclitaxel: A Gynecologic Oncology Group study

Intraperitoneal Radioactive Phosphorus (32P) Versus Observation After Negative Second-Look Laparotomy for Stage III Ovarian Carcinoma: A Randomized Trial of the Gynecologic Oncology Group

A Phase I Clinical Trial of the Poly(ADP-ribose) Polymerase Inhibitor Veliparib and Weekly Topotecan in Patients with Solid Tumors

Phase III Trial of Paclitaxel at Two Dose Levels, the Higher Dose Accompanied by Filgrastim at Two Dose Levels in Platinum-Pretreated Epithelial Ovarian Cancer: An Intergroup Study

Impact of tumour histology on survival in advanced cervical carcinoma: an NRG Oncology/Gynaecologic Oncology Group Study

Clinical results and quality of life analysis for the MVAC combination (methotrexate, vinblastine, doxorubicin, and cisplatin) in carcinoma of the uterine cervix: A Gynecologic Oncology Group study

Influence of race on tolerance of platinum-based chemotherapy and clinical outcomes in women with advanced and recurrent cervical cancer: a pooled analysis of 3 Gynecologic Oncology Group studies

Prevention, Diagnosis, and Treatment of Cervical Cancer

Phase II trial of dacarbazine, mitomycin, doxorubicin, and cisplatin with sargramostim in uterine leiomyosarcoma: A Gynecologic Oncology Group study

Suchergebnisse filtern